Day 1 Recap: Elevate-Derm West 2024
Catch up on coverage from the first day of the 2024 Elevate-Derm West Conference in Scottsdale, Arizona.
Related Articles
Dermatology Times’ Parent Company, MJH Life Sciences, Acquires Revolutionizing Atopic Dermatitis (RAD) Conference
RAD will join MJH’s multichannel model, enhancing its educational impact in atopic dermatitis, alopecia areata, vitiligo, and eczema.
Quality of Life Severely Affected for Patients with GPP
4 case histories highlight the physical and psychosocial burden of generalized pustular psoriasis.
The Impact of AR and VR in Enhancing Patient Care and Engagement in Cosmetic Care
Researchers noted that ethical use of AR and VR in cosmetic care requires balancing technological benefits with patient safety and privacy.
Off-Treatment Remission Achieved with Dupilumab for Pediatric AD
The LIBERTY-AD PED-OLE study showed clinical remission for moderate to severe atopic dermatitis.
Revertant Mosaic Skin Punch Grafting in Recessive Dystrophic Epidermolysis Bullosa
This case report describes a patient with severe generalized recessive dystrophic epidermolysis bullosa who presented with an unhealed ulcer that had persisted for the past…
Home
Cardiovascular disease (CVD) is the leading cause of death among women, responsible for one in three deaths every year in the US, often manifesting with…
Home
Medscape is pleased to present three live symposiums in San Diego in November 2024. Each event features expert panelists who will guide interactive discussions and…
Oral Minoxidil vs Topical Minoxidil for Male Androgenetic Alopecia
This randomized clinical trial compares the efficacy, safety, and tolerability of daily oral minoxidil, 5 mg, with twice-daily topical minoxidil, 5%, for 24 weeks in…
Benzene Concerns in Benzoyl Peroxide Spark Calls for Safer Acne Treatment Standards
As news of benzene contamination in benzoyl peroxide products continues to raise safety discussions, Steve Xu, MD, MSc, advocates for stricter regulations, increased research, and…